Infertility Treatment Devices Market Report by Type, Patient Type, End User, and Region 2024-2032
불임 치료 기기 세계 시장 규모는 2023년 4억 5,060만 달러에 달했습니다. 향후 IMARC 그룹은 시장이 2032년까지 7억 2,950만 달러에 이르며, 2024년과 2032년 사이에 5.4%의 성장률(CAGR)을 보일 것으로 예측됩니다.
불임증은 남성 또는 여성의 생식 기관의 질병으로, 12개월 이상 지나도 임신에 이르지 않는 것입니다. 일반적으로, 남성 생식계에서는 정액의 배출에 문제가 있는 것, 여성 생식계에서는 난소, 자궁, 난관, 내분비계에 이상이 있는 것이 원인이 됩니다. 체외수정(IVF)이나 현미수정(ICSI) 등의 생식보조의료(ART)나 자궁내 인공수정(IUI) 등의 인공수정법을 이용하여 치료됩니다. 현재 세계적으로 다낭성 난소 증후군(PCOS) 등의 유병률이 상승하고 있기 때문에 불임 치료 기기 수요가 증가하고 있습니다.
불임 치료 기기 시장 동향 :
세계 불임 치료 클리닉의 수가 증가하고 있다는 것은 시장 성장을 가속하는 중요한 요소 중 하나입니다. 또한, 앉기 쉬운 생활 습관에 의한 운동 부족은 당뇨병, 비만, 고혈압 등의 만성 질환의 발병으로 이어지고 있으며, 이들은 남녀의 불임으로 이어지는 잠재적인 위험 인자입니다. 그 결과, 동결 배아나 기증자 난자·정자를 이용하는 체외수정(IVF) 등의 ART의 이용이 증가하고 있습니다. 이것은 수많은 불임 치료 기기가 사용 가능 해지고 있다는 점에서 시장에 긍정적인 영향을 미칩니다. 이 외에도 주요 기업은 기술 진보를 도입하고 임신 성공률을 향상시키는 기술을 개발하고 있습니다. 또한 존재감을 높이고 고객 기반을 확대하기 위해 전략적 개발, 국내 기업와의 계약/제휴, 지리적 확대, 인수합병(M&A)에 점점 주력하고 있습니다. 시장 성장에 기여하는 기타 요인으로는 출생률 감소, 관민 투자 증가, 불임 치료에 대한 접근성을 높이기 위한 정부의 이니셔티브 등이 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 불임 치료 기기 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 분석 : 유형별
- 정자 분리 기기
- 난자흡입펌프
- 정자 분석 시스템
- 마이크로 매니퓰레이터 시스템
- 인큐베이터
- 크라이오 시스템
- 영상 시스템
- 현미경
- 기타
제7장 시장 분석 : 환자 유형별
제8장 시장 분석 : 최종사용자별
- 불임 치료 클리닉
- 병원 및 기타 의료시설
- 임상연구기관
제9장 시장 분석 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
- 개요
- 구매자의 협상력
- 공급기업의 협상력
- 경쟁도
- 신규 진입업자의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 프로파일
- Ab Scientific Ltd
- Cook Group Incorporated
- Coopersurgical Inc.(The Cooper Companies Inc.)
- Eppendorf
- Esco Micro Pte. Ltd.
- Genea Limited
- Hamilton Throne Ltd.
- Kitazato Corporation
- Rocket Medical plc
- Thermo Fisher Scientific
- Thomas Medical(Medgyn Products Inc.)
- Vitrolife
JHS
The global infertility treatment devices market size reached US$ 450.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 729.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.
Infertility is a disease of the male or female reproductive system wherein attempts to achieve pregnancy after 12 months or more fail. It is generally caused by problems in the ejection of semen in the male reproductive system or abnormalities in the ovaries, uterus, fallopian tubes, and the endocrine system of the female reproductive system. It is treated using assisted reproductive technology (ART) procedures, such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), and artificial insemination methods like intrauterine insemination (IUI). At present, there is a rise in the demand for infertility treatment devices on account of the rising prevalence of conditions like polycystic ovary syndrome (PCOS) around the world.
Infertility Treatment Devices Market Trends:
The increasing number of fertility clinics across the globe represents one of the key factors propelling the growth of the market. Moreover, lack of physical activities on account of sedentary lifestyles has led to the development of chronic diseases, such as diabetes, obesity, and hypertension, which are potential risk factors leading to infertility among men and women. Consequently, there is a rise in the use of ART procedures, such as IVF, which involves the utilization of previously frozen embryos and donor eggs or sperm. This, coupled with the growing availability of numerous infertility treatment devices, is positively influencing the market. Apart from this, key players are introducing technological advancements and developing techniques that improve the conception success rate. They are also increasingly focusing on strategic developments, agreements/partnerships with domestic players, geographical expansions, and mergers and acquisitions (M&A) to increase their presence and widen their customer-base. Some of the other factors contributing to the market growth include declining fertility rates, rising public-private investments and government initiatives to increase the accessibility of infertility treatments.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility treatment devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, patient type and end user.
Breakup by Type:
Sperm Separation Devices
Ovum Aspiration Pumps
Sperm Analyzer Systems
Micromanipulator Systems
Incubators
Cryosystems
Imaging Systems
Microscopes
Others
Breakup by Patient Type:
Female Infertility Treatment
Male Infertility Treatment
Breakup by End User:
Fertility Clinics
Hospitals and Other Healthcare Facilities
Clinical Research Institutes
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ab Scientific Ltd, Cook Group Incorporated, Coopersurgical Inc. (The Cooper Companies Inc.), Eppendorf, Esco Micro Pte. Ltd., Genea Limited, Hamilton Throne Ltd., Kitazato Corporation, Rocket Medical plc, Thermo Fisher Scientific, Thomas Medical (Medgyn Products Inc.), Vitrolife.
Key Questions Answered in This Report:
- How has the global infertility treatment devices market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global infertility treatment devices market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the patient type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global infertility treatment devices market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Infertility Treatment Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Sperm Separation Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Ovum Aspiration Pumps
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Sperm Analyzer Systems
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Micromanipulator Systems
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Incubators
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Cryosystems
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Imaging Systems
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 6.8 Microscopes
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
- 6.9 Others
- 6.9.1 Market Trends
- 6.9.2 Market Forecast
7 Market Breakup by Patient Type
- 7.1 Female Infertility Treatment
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Male Infertility Treatment
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by End User
- 8.1 Fertility Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Hospitals and Other Healthcare Facilities
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Clinical Research Institutes
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Ab Scientific Ltd
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Cook Group Incorporated
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Coopersurgical Inc. (The Cooper Companies Inc.)
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Eppendorf
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 SWOT Analysis
- 14.3.5 Esco Micro Pte. Ltd.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Genea Limited
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Hamilton Throne Ltd.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.8 Kitazato Corporation
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Rocket Medical plc
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Thermo Fisher Scientific
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Thomas Medical (Medgyn Products Inc.)
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Vitrolife
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
